Country for PR: China
Contributor: PR Newswire Asia (China)
Tuesday, January 10 2023 - 23:30
Complete Genomics Launches Full Sequencing Platforms at Biotech Showcase(TM) 2023
SAN FRANCISCO, Jan. 10, 2023 /PRNewswire-AsiaNet/ --

Complete Genomics Inc (, a subsidiary 
of MGI Tech Co., Ltd. ("MGI"), today unveiled its full sequencing platforms at 
Biotech Showcase during JP Morgan Healthcare Conference Week 2023. Rade 
Drmanac, PhD, Chief Scientific Officer, announced "free three-month trial" 
program and "reagent rental leasing" program, giving customers the opportunity 
to experience the quality and reliability of its products before purchasing 

Founded in 2006 in Silicon Valley, Complete Genomics is a leading innovator of 
high-throughput sequencing technologies, with end-to-end multi-omics platforms 
including genetic sequencing and laboratory automation. Complete Genomics 
developed its own patented DNA nanoball-based sequencing technology DNBSEQâ„¢. 
Featuring DNBs (DNA NanoBalls) with high signal density on patterned nanoarray 
to greatly improve detection accuracy and efficiency, DNBSEQ boasts high 
performance in applications such as WGS (whole-genome sequencing)/WES 
(whole-exome sequencing) with low duplication rates and higher Indel 
accuracies. This innovative technology eliminates index hopping and clonal 
errors during the sequencing step of the workflow, facilitating greater 
accuracy and flexibility.

Dr. Drmanac introduced a series of DNBSEQ technology-based sequencing platforms 
that are available in the US market, including DNBSEQ-G400C*, a day-to-day, 
medium throughput benchtop sequencer that can flexibly support a variety of 
different sequencing modes, which was launched in the US last year.

As Complete Genomics enters 2023, it offers more innovative sequencing 
platforms for US customers to power their genomics research and related 
efforts. These offerings range from low to ultra-high throughput to meet 
diverse needs, which include:

DNBSEQ-E25* as a portable sequencer with a very low throughput of up to 7.5 Gb 
daily. Easy setup makes it ready to run in ten minutes, coupled with fast 
turnaround time of ~ 20 hours from DNA samples to FASTQ data. This product will 
be launched in Q2 2023.
DNBSEQ-T7* as an ultra-high throughput sequencer that offers one of the highest 
flexibilities among sequencers in the market with four independent flow cells 
running at any time. With an output of 1-7 Tb of high-quality data per day, it 
can achieve over 20,000 of 30X WGS in less than one year. This highly efficient 
and cost-effective sequencer is available now.
DNBSEQ-T10x4* as one of the world's largest and highest throughput next 
generation sequencers available with a robotic arm and data output of up to 18 
Tb daily. This product is available now.
Complete Genomics offers products from lab automation to data analysis/storage 
tools covering the full NGS workflow to accelerate scientific findings and 
breakthroughs in genomic medicine.

Based on DNBSEQ technology, which makes sequencing much more accurate, flexible 
and affordable, Complete Genomics has generated great interest within the 
scientific community and formed partnerships with various life science 
companies and scientific institutions. In August 2022, its DNBSEQ-G400C 
sequencer was released in the US with immediate adoption in dozens of customer 
labs and partnerships with various life science companies, including Sentieon, 
a developer of highly accurate and optimized algorithms for bioinformatics 
applications. "Complete Genomics provides high-quality, accurate and accessible 
products, giving the genomics community a 'Power of Choice' in sequencing. We 
look forward to providing even more innovative platforms through future 
partnerships to meet the diverse needs of the life science industry," said Jun 
Ye, CEO of Sentieon.

"In the past years, we are winning the recognition of more and more US 
customers through advanced patented technologies, high-quality products, and 
professional services," said Dr. Drmanac. "We do not just sell products; we 
enable partners. Through understanding the latest genomics needs of the US 
market, providing early product access, and fostering collaborations with local 
partners, we seek to further advance life science and provide customers around 
the globe with 'the right for another choice.'"

Through Complete Genomics new "free three-month trial" program, participating 
institutions will gain access to selected sequencing platforms. Complete 
Genomics is offering a money back guarantee if customers are not completely 
satisfied with their instrument purchase. To further support the financial 
commitment, Complete Genomics offers qualified professionals the opportunity to 
apply for the reagent rental leasing program. For further information, please 
reach out to

Complete Genomics takes data security seriously. All DNBSEQ sequencing 
platforms can work as a stand-alone system from sample to result without any 
internet connection, so there is no risk of data breaches. Customers will have 
100% control of their data security.

About Complete Genomics
Complete Genomics Inc, a subsidiary of MGI Tech Co., Ltd., is a global life 
science company offering lab automation and a comprehensive high throughput 
sequencing product portfolio. Founded in 2006 and currently located in San 
Jose, California, Complete Genomics maintains a demo lab and full supply center 
with all of the reagents, lab automation equipment and sequencers locally 
stored for customers. Complete Genomics released its first next-generation 
sequencing system, the DNBSEQ-G400C* platform in the US, in August 2022. For 
all sequencer specifications, please visit the Complete Genomics website.

*Unless otherwise informed, StandardMPS and CoolMPS sequencing reagents, and 
sequencers for use with such reagents, are not available in Germany, Spain, UK, 
Sweden, Belgium, Italy, Finland, Czech Republic, Switzerland, Portugal, 
Austria, and Romania. Unless otherwise informed, StandardMPS sequencing 
reagents, and sequencers for use with such reagents are not available in Hong 

Shani Lewis
Assistant Vice President, Media
(617) 865-5554

Dada Zhang
Senior Public Relationship Manager
Complete Genomics

SOURCE: Complete Genomics